Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
108,074,661
-
Total 13F shares
-
10,288,500
-
Share change
-
+10,288,500
-
Total reported value
-
$277,169,982
-
Price per share
-
$26.94
-
Number of holders
-
33
-
Value change
-
+$277,169,982
-
Number of buys
-
33
Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock (ACRS) as of Q4 2015
As of 31 Dec 2015,
Aclaris Therapeutics, Inc. - Common Stock (ACRS) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,288,500 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, Rock Springs Capital Management LP, Cormorant Asset Management, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, TURNER INVESTMENTS, L.P., NORTHERN TRUST CORP, and NORGES BANK.
This page lists
33
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.